Priming dose of phenylhydrazine protects against hemolytic and lethal effects of 2-butoxyethanol

Toxicology and Applied Pharmacology

Volumn 225, Issue 1, 2007, Pages 102-112

  Palkar, Prajakta S ^a   Philip, Binu K ^a   Reddy, Ramesh N ^a   Mehendale, Harihara M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Butoxyethanol; Erythropoiesis; Hemolysis; Phenylhydrazine; Resiliency of RBCs

Indexed keywords

2 BUTOXYETHANOL; ALCOHOL; ALDEHYDE DEHYDROGENASE; BUTOXYACETIC ACID; CATALASE; ERYTHROPOIETIN; GLUTATHIONE; PHENYLHYDRAZINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEMATOCRIT; HEMOLYSIS; LETHAL DOSE; NONHUMAN; RAT; RETICULOCYTE COUNT; TOXICOKINETICS; URINARY EXCRETION;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIOXIDANTS; ERYTHROCYTES; ERYTHROPOIESIS; ETHYLENE GLYCOLS; FEMALE; GLYCOLATES; HEMATOCRIT; HEMOLYSIS; OXIDANTS; PHENYLHYDRAZINES; RATS; RATS, SPRAGUE-DAWLEY; RETICULOCYTES; TIME FACTORS;

RATTUS;

EID: 35549007213     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.06.011     Document Type: Article

References (49)

1. Abraham E.C., Taylor J.F., and Lang C.A. Influence of mouse age and erythrocyte age on glutathione metabolism. Biochem. J. 174 (1978) 819-825
2. Ades I.Z., and Cascarano J. Mitochondrial alterations in heart, kidney and liver of rats subjected to anemic hypoxia. Exp. Mol. Pathol. 30 (1979) 94-109
3. Anand S.S., Philip B.K., Palkar P.S., Mumtaz M.M., Latendresse J.R., and Mehendale H.M. Adaptive tolerance in mice upon subchronic exposure to chloroform: increased exhalation and target tissue regeneration. Toxicol. Appl. Pharmacol. 213 (2006) 267-281
4. Badger T.M., Hoog J.O., Svensson S., McGehee Jr. R.E., Fang C., Ronis M.J., and Ingelman-Sundberg M. Cyclic expression of class I alcohol dehydrogenase in male rats treated with ethanol. Biochem. Biophys. Res. Commun. 274 (2000) 684-688
5. Badger T.M., Hidestrand M., Shankar K., McGuinn W.D., and Ronis M.J. The effects of pregnancy on ethanol clearance. Life Sci. 77 (2005) 2111-2126
6. Bartnik F.G., Reddy A.K., Klecak G., Zimmermann V., Hostynek J.J., and Kunstler K. Percutaneous absorption, metabolism, and hemolytic activity of n-butoxyethanol. Fundam. Appl. Toxicol. 8 (1987) 59-70
7. Barton C.C., Bucci T.J., Lomax L.G., Warbritton A.G., and Mehendale H.M. Stimulated pulmonary cell hyperplasia underlies resistance to alpha-naphthylthiourea. Toxicology 143 (2000) 167-181
8. Beutler E. Drug-induced hemolytic anemia. Pharmacol. Rev. 21 (1969) 73-103
9. Bustamante E., Soper J.W., and Pedersen P.L. A high-yield preparative method for isolation of rat liver mitochondria. Anal. Biochem. 80 (1977) 401-408
10. 4 toxicity by prestimulation of hepatocellular regeneration in partially hepatectomized gerbils. Biochem. Pharmacol. 42 (1991) 633-644
11. Carpenter C.P., Keck G.A., Nair III J.H., Pozzani U.C., Smyth Jr. H.F., and Weil C.S. The toxicity of butyl Cellosolve solvent. AMA Arch. Ind. Health 14 (1956) 114-131
12. Chanda S., Mangipudy R.S., Warbritton A., Bucci T.J., and Mehendale H.M. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology 21 (1995) 477-486
13. Dambrauskas T., and Cornish H.H. Effect of pretreatment of rats with carbon tetrachloride on tolerance development. Toxicol. Appl. Pharmacol. 17 (1970) 83-97
14. Ghanayem B.I. Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro. Biochem. Pharmacol. 38 (1989) 1679-1684
15. Ghanayem B.I., and Sullivan C.A. Assessment of the haemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans. Hum. Exp. Toxicol. 12 (1993) 305-311
16. Ghanayem B.I., Burka L.T., Sanders J.M., and Matthews H.B. Metabolism and disposition of ethylene glycol monobutyl ether (2-butoxyethanol) in rats. Drug Metab. Dispos. 15 (1987) 478-484
17. Ghanayem B.I., Sanchez I.M., and Matthews H.B. Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms. Toxicol. Appl. Pharmacol. 112 (1992) 198-206
18. Grattagliano I., Russmann S., Palmieri V.O., Portincasa P., Palasciano G., and Lauterburg B.H. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin. Pharmacol. Ther. 78 (2005) 422-432
19. Itano H.A., Hirota K., and Vedvick T.S. Ligands and oxidants in ferrihemochrome formation and oxidative hemolysis. Proc. Natl. Acad. Sci. U. S. A. 74 (1977) 2556-2560
20. Jain S.K., and Subrahmanyam D. Life span of phenylhydrazine-induced reticulocytes in albino rats. Indian J. Exp. Biol. 16 (1978) 255-257
21. Jain S.K., and Hochstein P. Membrane alterations in phenylhydrazine-induced reticulocytes. Arch. Biochem. Biophys. 201 (1980) 683-687
22. Kellermeyer R.W., Tarlov A.R., Brewer G.J., Carson P.E., and Alving A.S. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis. JAMA 180 (1962) 388-394
23. King K.E., and Ness P.M. Treatment of autoimmune hemolytic anemia. Semin. Hematol. 42 (2005) 131-136
24. Korrapati M.C., Lock E.A., and Mehendale H.M. Molecular mechanisms of enhanced renal cell division in protection against S-1,2-dichlorovinyl-l-cysteine-induced acute renal failure and death. Am. J. Physiol. Renal Physiol. 289 (2005) F175-F185
25. Korrapati M.C., Chilakapati J., Lock E.A., Latendresse J.R., Warbritton A., and Mehendale H.M. Preplaced cell division-a critical mechanism of autoprotection against S-1,2-dichlorovinyl-l-cysteine-induced acute renal failure and death in mice. Am. J. Physiol. Renal Physiol. 291 (2006) F439-F455
26. Korrapati, M.C., Chilakapati, J., Witzmann, F.A., Chundury, R., Lock, E.A., Mehendale, H.M., 2007. Proteomics of S-(1, 2-dichlorovinyl)-L-cysteine-induced acute renal failure and autoprotection in mice. Am. J. Physiol. Renal Physiol. In Press.
27. Limaye P.B., Apte U.M., Shankar K., Bucci T.J., Warbritton A., and Mehendale H.M. Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants. Toxicol. Appl. Pharmacol. 191 (2003) 211-226
28. Limaye P.B., Bhave V.S., Palkar P.S., Apte U.M., Sawant S.P., Yu S., Latendresse J.R., Reddy J.K., and Mehendale H.M. Upregulation of calpastatin in regenerating and developing liver: role in resistance against hepatotoxicity. Hepatology 44 (2006) 379-388
29. Magos L., Webb M., and Butler W.H. The effect of cadmium pretreatment on the nephrotoxic action and kidney uptake of mercury in male and female rats. Br. J. Exp. Pathol. 55 (1974) 589-594
30. Mangipudy R.S., Chanda S., and Mehendale H.M. Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ. Health Perspect. 103 (1995) 260-267
31. Mehendale H.M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 33 (2005) 41-51
32. Mehendale H.M., and Limaye P.B. Calpain: a death protein that mediates progression of liver injury. Trends Pharmacol. Sci. 26 (2005) 232-236
33. Naughton B.A., Moore E., Bush M.E., Lapin D.M., and Dornfest B.S. Hemostatic alterations associated with phenylhydrazine-induced anemia in the rat. J. Med. 20 (1989) 305-330
34. Oken D.E., Mende C.W., Taraba I., and Flamenbaum W. Resistance to acute renal failure afforded by prior renal failure: examination of the role of renal renin content. Nephron 15 (1975) 131-142
35. Philip B.K., Anand S.S., Palkar P.S., Mumtaz M.M., Latendresse J.R., and Mehendale H.M. Subchronic chloroform priming protects mice from a subsequently administered lethal dose of chloroform. Toxicol. Appl. Pharmacol. 216 (2006) 108-121
36. Poet T.S., Soelberg J.J., Weitz K.K., Mast T.J., Miller R.A., Thrall B.D., and Corley R.A. Mode of action and pharmacokinetic studies of 2-butoxyethanol in the mouse with an emphasis on forestomach dosimetry. Toxicol. Sci. 71 (2003) 176-189
37. Pound A.W., and Lawson T.A. Reduction of carbon tetrachloride toxicity by prior administration of a single small dose in mice and rats. Br. J. Exp. Pathol. 56 (1975) 172-179
38. Reinhart W.H., Sung L.P., and Chien S. Quantitative relationship between Heinz body formation and red blood cell deformability. Blood 68 (1986) 1376-1383
39. Rettig M.P., Low P.S., Gimm J.A., Mohandas N., Wang J., and Christian J.A. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood 93 (1999) 376-384
40. Sawant S.D., Doucet P.G., Slob W., Blaylock B.L., and Mehendale H.M. Experimental mathematical validation of a novel concept of extended 2-butoxyethanol autoprotection. Int. J. Toxicol. 18 (1999) 307-316
41. Schreihofer A.M., Hair C.D., and Stepp D.W. Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 288 (2005) R253-R261
42. Shetlar M.D., and Hill H.A. Reactions of hemoglobin with phenylhydrazine: a review of selected aspects. Environ. Health Perspect. 64 (1985) 265-281
43. Sivarao D.V., and Mehendale H.M. 2-Butoxyethanol autoprotection is due to resilience of newly formed erythrocytes to hemolysis. Arch. Toxicol. 69 (1995) 526-532
44. 3 in rats pretreated with chlordecone, phenobarbital, or mirex. Toxicol. Appl. Pharmacol. 109 (1991) 514-528
45. Udden M.M. In vitro sub-hemolytic effects of butoxyacetic acid on human and rat erythrocytes. Toxicol. Sci. 69 (2002) 258-264
46. Udden M.M. Effects of diethylene glycol butyl ether and butoxyethoxyacetic acid on rat and human erythrocytes. Toxicol. Lett. 156 (2005) 95-101
47. Udden M.M., and Patton C.S. Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: I. Sensitivity in rats and resistance in normal humans. J. Appl. Toxicol. 14 (1994) 91-96
48. Udden M.M., and Patton C.S. Butoxyacetic acid-induced hemolysis of rat red blood cells: effect of external osmolarity and cations. Toxicol. Lett. 156 (2005) 81-93
49. Vaidya V.S., Shankar K., Lock E.A., Bucci T.J., and Mehendale H.M. Role of tissue repair in survival from s-(1,2-dichlorovinyl)-l-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol. Sci. 74 (2003) 215-227